Aug 082016
Talent4Boards - Great Talent builds Great Boards
– USA, MD – REGENXBIO Inc. (NASDAQ:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy based on its proprietary NAV Technology Platform, today announced the appointment of Daniel J.… => Read more
REGENXBIO appointed Dan Abdun-Nabi to its Board of Directors
From:: REGENXBIO appointed Dan Abdun-Nabi to its Board of Directors
Sorry, the comment form is closed at this time.